Join SOPHiA GENETICS at SFMPP 2026 in Paris, France! Come meet our team of experts at Booth #16. We are looking forward to discussing how we support laboratories and healthcare institutions with scalable, data-driven solutions. 

Stay tuned for information and session updates!

SOPHiA GENETICS is proud to join the 37th CBGM in São Luís, Maranhão (Sept 2–5, 2026), celebrating 40 years of SBGM and the future of precision medicine in Brazil. Meet us at Booth #20 to discover the latest innovations of the New Generation SOPHiA DDM™ Platform, with a special focus on Exome advancements.

We are excited to attend SITC EU 2026 in Lausanne and connect with the European immunotherapy community to exchange insights on the latest advances in innovative therapies.

Join our BioPharma team to discover how AI-powered technology and diagnostics are helping advance precision oncology.

We are excited to join the 26th ACGH Congress — Asociación Colombiana de Genética Humana, taking place August 13–15 in Pereira, Colombia. Join us and meet our LATAM team to learn how SOPHiA DDM™ helps clinical genetics laboratories across the region implement optimized, technology-agnostic genomic testing — from exome design to actionable diagnosis.

The SOPHiA GENETICS team is looking forward to seeing you at our sponsored academic breakfast talk.

Academic Breakfast Talk on Friday, August 14th, from 8:00 to 9:00 am — Salón 1, Genética Médica.

"From Design to Diagnosis: Implementation of Optimized Exomes in Clinical Practice"

Luna Rodríguez, MSc., Subject Matter Expert, SOPHiA GENETICS
Dr. Coztli Ocelotl Azotla, Geneticist, Genos Médica

In this talk, we will explore how optimized exome design is reshaping clinical genetics workflows across Latin America, bridging the gap between test design and real-world diagnostic impact.

• Explore how optimized exome sequencing strategies improve diagnostic yield while streamlining laboratory workflows in clinical genetics.
• Discover how a technology-agnostic platform like SOPHiA DDM™ enables laboratories of different sizes and infrastructures to implement standardized, scalable genomic testing.
• Gain insights from real-world clinical experience on integrating optimized exomes into everyday diagnostic practice, supported by a case-based perspective from Genos Médica.

Come find us at booth #19 for expert discussions and collaborative opportunities.

The SOPHiA GENETICS™ Global Precision Medicine Forum returns to ESMO! Join us on October 22^nd at 3:00 PM CET at the Novotel Madrid Campo de las Naciones, Madrid, Spain, for its 2026 edition.

The liquid biopsy movement continues. Building on the conversation started by SOPHiA GENETICS and Memorial Sloan Kettering Cancer Center (MSK) at ASCO 2026, this forum explores how expanding access to liquid biopsy is now translating into clinical action. Join the pioneers driving this transformation as they share real-world insights from routine practice, demonstrate how decentralized testing is shaping patient care, and reveal how the same model is enabling the next generation of precision oncology biomarkers.

Join Pharma and Biotech leaders, oncology KOLs, and diagnostic partners to explore The Liquid Biopsy Movement: From Access to Action, and how it is reshaping the future of cancer care.

Across different sessions, the forum will explore:

• Liquid biopsy: From Deployment to Daily Practice
• A Blueprint for the Next Generation Biomarkers
• Strategic Innovation Through Partnerships
• Validation as a Shared Responsibility

Don’t miss this unique opportunity and reserve your spot now!

We are delighted to participate in the ESMO AI & Digital Oncology Congress 2026, where you can meet with our Multimodal and BioPharma teams for three exciting days of innovation, networking, and insights into AI-powered solutions and breakthroughs to transform precision oncology.

Join us at booth #11 to:

• Explore how the SOPHiA DDM™ Platform transforms complex multimodal oncology data into actionable insights with AI-powered analytics
• Empower more confident decision-making with SOPHiA DDM™ Digital Twins by comparing similar patient profiles and simulating potential response outcomes
• Harness the global collective intelligence of our network to uncover valuable insights and advance precision oncology through data-driven innovation

SOPHiA GENETICS is at the 17th Annual Meeting of the Cancer Genomics Consortium. Find us at Booth #29 to see how the SOPHiA DDM™ Platform is helping laboratories move from fragmented workflows to AI-driven, integrated, end-to-end solutions, able to generate actionable, evidence-based insights at scale.

Discover a platform built for the complexity of cancer genomics, across solid tumors and hematologic malignancies, driven by its global community and trusted by 990+ institutions across 75 countries.

Drop by our booth for an in-depth demo of our end-to-end applications:

Booth #29 hours:

• Sun Aug 2, 3:15 PM–8:00 PM
• Mon Aug 3, 8:00 AM–6:30 PM
• Tues Aug 4, 8:00 AM–5:30 PM
• Wed Aug 5, 8:00 AM–11:15 AM 

Learn more:

• See MSK-IMPACT® Flex powered with SOPHiA DDM™ in action, comprehensive genomic profiling that spans DNA and RNA capture, as well as lpWGS
• Explore our SOPHiA DDM™ for Blood Cancers, built to help labs future-proof their workflows from detection through MRD (minimal residual disease) monitoring
• Learn how our collaboration with Memorial Sloan Kettering Cancer Center (MSK) is decentralizing world-class genomic capabilities for clinical researchers beyond flagship centers
• Get a personalized demo from our oncology and genomics specialists

Don't miss: 🎤 Science Café Presentation,  Lizmery Ferguson Schires | Royal Sonesta Houston Galleria

Whether you're running a high-volume solid tumor program or building out comprehensive hemato-oncology capabilities, our team can show you how SOPHiA DDM™ streamlines the entire process, from concept to implementation.

Book 15 minutes with our team now or simply stop by our booth. See you in Houston.

One workflow, entirely in-house.

Most lab leaders arrive at ADLM with the same question: how do we bring NGS in-house, or scale what we already run, without adding headcount, cost, or turnaround time?

At Booth #1172, the AVITI24 system and the SOPHiA DDM™ Platform’s AI-powered analysis run as one connected workflow. Your lab sequences and interprets its own data, and your data stays in-house.

780+ institutions run SOPHiA DDM™ today
70+ countries, standardizing and scaling NGS workflows

Stop by Booth #1172, wherever your lab is.
Tell us where you are, and we’ll tailor the conversation.

Booth #1172 hours:
Tue Jul 28, 9:30 AM–5:00 PM
Wed Jul 29, 9:30 AM–5:00 PM
Thu Jul 30, 9:30 AM–12:00 PM

Launching an NGS program

See how to stand up sequencing and analysis together, without building a bioinformatics team from scratch.

Running an established program

See where SOPHiA DDM™ removes the bottlenecks you already feel: variant interpretation time, workflow standardization, and QC overhead.

Weighing in-house economics

Walk through the cost and turnaround math labs are using to build the business case for in-house testing.

Whether you’re evaluating NGS solutions, expanding your test menu, or exploring how AI can strengthen your genomic pipeline, our teams are ready to talk.

Book 15 minutes with our team now, or simply stop by and say hello. See you in Anaheim.

El GENOMiCS INSIGHTS Day Costa Rica se llevará a cabo el próximo 28 de julio, en el Hotel Four Points. El evento contará con la participación de especialistas y clientes que compartirán su experiencia real en la práctica clínica, abordando temas de alto impacto: desde el estudio de exoma completo en población costarricense hasta la caracterización molecular de neoplasias mieloides mediante secuenciación NGS.

La jornada reunirá experiencias concretas de clientes que utilizan la plataforma SOPHiA DDM™ en su día a día, ofreciendo una perspectiva directa sobre su impacto en el diagnóstico molecular y la toma de decisiones clínicas. El evento culminará con una mirada hacia el horizonte de la genómica en hemato-oncología, presentada por nuestro equipo de expertos.

 A continuación, encontrará la agenda preliminar del evento

What: SOPHiA GENETICS Exclusive Networking event

Where: Four Points by Sheraton Sabana

Date: 28 de julio

Time: 14h00-17h:00

Agenda

Why Attend?

Descubra SOPHiA DDM™: una plataforma compatible con múltiples tecnologías, con infinitas posibilidades

Conozca cómo SOPHiA DDM™ permite realizar análisis precisos en diversas áreas de la medicina, desde oncología hasta enfermedades raras.

Aborde los desafíos actuales de la práctica clínica y la investigación

Participe en una conversación sobre el futuro de las instituciones de salud e investigación y descubra cómo aprovechar el potencial de los datos de secuenciación de nueva generación (NGS) para generar resultados rápidos, sólidos y accionables que faciliten una toma de decisiones informada.

Conecte con líderes de opinión y expertos del sector

Interactúe con colegas, investigadores y usuarios de la plataforma SOPHiA DDM™ en un espacio diseñado para el intercambio de conocimientos, experiencias y oportunidades de colaboración científica.

Join SOPHiA GENETICS™ and ARC Regulatory for an exclusive Industry Reception bringing together precision medicine and pharma leaders in Boston on July 21^st.

Following our recently announced Master Collaboration Agreement, this event will spotlight our integrated solution for pharma companies across the clinical development lifecycle in Europe, combining ARC's IVDR regulatory expertise with SOPHiA GENETICS' NGS technology and CE-IVD track record.

You’ll hear directly from both teams about key milestones, including the co-development of a Clinical Trial Assay (CTA) designed to accelerate patient recruitment in European clinical trials.

Accelerate with Impact: Expanding Patient Access to Precision Medicine Across the EU

The programme will be followed by a networking reception, offering a unique opportunity to connect with peers and leaders shaping the future of precision medicine.

Reserve your spot today!